Patient's persistence leads to rare kidney disease diagnosis and breakthrough treatment

Michelle Williams endured years of undiagnosed illness with progressive swelling, fatigue, and kidney damage before finally receiving proper diagnosis and treatment.

For years, Michelle Williams carried an illness that medicine had no name for and no remedy to offer — her body failing in ways that specialists dismissed or misread, her future quietly narrowing toward kidney failure. The approval of pegcetacoplan, now known as Empaveli, marks the first time science has offered a genuine answer to IC-MPGN, a kidney disease so rare it touches only a handful of people per million. It is a reminder that the rarest suffering is not the least real, and that persistence — a patient's, a physician's, a researcher's — can eventually bend the arc of a disease once tho

Patient's persistence leads to rare kidney disease diagnosis and breakthrough treatment

Cobertura Relacionada

Receba o Register no seu e-mail